Assessments
toxicity, Neutropenia
BLOOD, NEUTROPENIA, ADVERSE EVENT
Blood test was done once a week or according to physician decision, whereas physical examination and evaluation for toxicity were repeated weekly during treatment. Neutropenia, FN, and safety evaluation were graded and evaluated according to the Common Terminology Criteria for Adverse Events (CTCAE 5.0) of the World Health Organization. Chemotherapy or radiotherapy delay was defined as suspension of the schedule of treatment for more than one week.